PNEUMOVAX 23 contains a mixture of inactive parts from 23 of the most common types of pneumococcal bacteria. PNEUMOVAX 23 is a vaccine given to help prevent infections caused by certain types of ...
The vaccine showed promising results in clinical trials. Although the prevention of pneumonia caused by specific pneumococcal ...
Sanofi is handing SK bioscience 50 million euros ($52 million) as the longtime partners take their next-gen pneumococcal ...
An all-encompassing guide to understanding vaccines. The Bonus Protections of Routine VaccinesVaccination can bring more than just one unexpected benefit. CDC Recommends People Ages 50 to 64 Get ...